SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$0.42
-0.04 (-8.65%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+8,524.5% upside
Low Target
$26.81
Average Target
$36.24
High Target
$52.45
Current Price
$0.42
Current
$0.42
$0.42
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Scenario Analysis
Bear Case
$26.81
6,280.3%
Low target
Base Case
$36.24
+8,524.5%
Avg target
Bull Case
$52.45
+12,382.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$89.80
-99.5% from high
52-Week Low
$1.50
+-72.0% from low
Target vs 52W High
$36.24
-59.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |